Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012
Cash flows from operating activities:
Net loss	$ (33,597)		$ (54,037)	[1],[2]
Adjustments to reconcile net loss to net cash used in operating activities:
Deferred income taxes	(99)		(5,516)	[1]
Depreciation and amortization	2,981		4,575	[1]
Impairment of goodwill and long-lived assets	23,004		51,214	[1]
Accretion of interest to related party liability	470		542	[1]
Amortization of debt issuance costs	502
Re-measurement of contingent consideration			(5,657)	[1]
Stock-based compensation expense	1,139		884	[1]
Pension charges	309
Loss on disposal of fixed assets			15	[1]
Changes in operating assets and liabilities:
Accounts receivable	(702)		574	[1]
Inventories	(2,001)		(1,539)	[1]
Prepaid expenses and other assets	412		(1,598)	[1]
Accounts payable	2,377		2,427	[1]
Liability to related party	(799)		(790)	[1]
Liability for consumer cards	1,008		(272)
Deferred revenue	396		995	[1]
Accrued expenses and other liabilities	2,506		784	[1]
Net cash used in operating activities	(2,094)		(7,399)	[1]
Cash flows from investing activities:
Capital expenditures	(1,456)		(1,709)	[1]
Restricted cash deposited for capital expenditure			(696)	[1]
Net cash acquired from acquisitions			572	[1]
Net cash used in investing activities	(1,456)		(1,833)	[1]
Cash flows from financing activities:
Proceeds from capital raise, net of issuance costs	9,053
Proceeds from issuance of common stock under ESPP	132		341	[1]
Cash paid for acquisition of noncontrolling interest	(72)		(500)	[1]
Restricted cash related to factoring arrangement			(1,321)	[1]
Payments on financial liabilities	(2,684)		(868)	[1]
Changes in bank line of credit, net	(177)		129	[1]
Net cash provided by (used in) financing activities	6,252		(2,219)	[1]
Effect of exchange rates on cash and cash equivalents	(539)		503	[1]
Net increase (decrease) in cash and cash equivalents	2,163		(10,948)	[1]
Cash and cash equivalents at beginning of period	7,378	[3]	17,239	[1]
Cash and cash equivalents at end of period	9,541		6,291	[1]
Supplemental disclosures of cash flows information:
Common stock issued in connection with business combinations			3,041	[1]
Common stock issued in connection with stock bonus and incentive plans	55		324	[1]
Common stock issued in connection with acquiring noncontrolling interest			1,168	[1]
Issuance of common stock in connection with earn-out agreement			128	[1]
Stock option grants in connection with stock bonus and incentive plans	48		99	[1]
Property and equipment subject to accounts payable	351		148	[1]
Leasehold improvements funded by lease incentives	$ 508

[1] Certain amounts shown in the table above have changed as compared to amounts reported in prior periods as noted in Item 1, Financial Statements, Note 1 of Notes to Condensed Consolidated Financial Statements, Reclassifications and Restatements.

[2] Certain amounts shown in the table above have changed as compared to amounts reported in prior periods as noted in Item 1, Financial Statements, Note 1 of Notes to Condensed Consolidated Financial Statements, Reclassifications and Restatements.

[3] The condensed consolidated balance sheet has been derived from the audited consolidated financial statements at December 31, 2012 but does not include all the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.